Physician profile
Beverly Drucker
NPI 1104834704
$11,978.24
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,647 · 2021: $3,631 · 2022: $1,842 · 2024: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $525 · Food and Beverage: $250 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $525.00 |
| Food and Beverage | $250.00 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $4,788.65 | 2019 | |
| Glaxosmithkline, LLC. | $1,969.25 | 2021 | |
| Genentech USA, INC. | $1,775.01 | 2019-2021 | |
| Astellas Pharma Global Development | $1,743.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $525.00 | 2024 | Lynparza |
| Stemline Therapeutics INC. | $250.00 | 2024 | Orserdu |
| Eisai INC. | $221.26 | 2019-2022 | |
| Celgene Corporation | $135.00 | 2019 | |
| Incyte Corporation | $125.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $123.75 | 2019 | |
| Abbvie INC. | $101.41 | 2019 | |
| Pfizer INC. | $83.99 | 2024 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Drucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.